home Apparatus

New Drug Expected For Patients With Low HER2 Expression, FDA Grants Priority Review Status To Enhertu

  • Mar 26, 2025

Newly Approved Targeted Drug Makes 79% Of Patients' Tumours Disappear Altogether, This Type Of Blood Tumour Is Saved!

  • Mar 25, 2025

Two-Drug Combination For Refractory Thyroid Cancer, 100% Effective!

  • Mar 24, 2025

Two-Drug Combination For Specific Mutation Colorectal Cancer With 100% Efficiency!

  • Mar 23, 2025

Pre-Operative Immunotherapy And More Than Half Of The Tumours In This Type Of Skin Cancer Disappear Completely!

  • Mar 22, 2025

Another Cancer-Independent Targeted Drug Approved! Up To 84% Efficacy!

  • Mar 21, 2025

New Findings Confirm: Excellent Data On This Bipotent Antibody Drug Against Ovarian Cancer!

  • Mar 20, 2025

FDA Grants Orphan Drug Status To Two New Therapies In a Row, And These Two Groups Of Patients Are Expected To Benefit!

  • Mar 19, 2025

Ovarian Cancer Heavyweight Cutting-Edge ADC Drug Elahere Proven Safe And Effective

  • Mar 18, 2025

Heavyweight! First ADC Drug Approved For Hormone Receptor-Positive Breast Cancer!

  • Mar 17, 2025